# DoD Vision Translational Research Award

Source: https://welltoldgrants.com/grants/ht9425-23-vrp-tra-dod-vision-translational-research-award/  
Official notice: https://www.grants.gov/search-results-detail/348080

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make one award worth $1.6 million in total. Applications closed on November 8, 2023.

| Field | Value |
|---|---|
| Opportunity number | HT9425-23-VRP-TRA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | November 8, 2023 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 1 |
| Total funding | $1.6 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

The FY23 VRP TRA is intended to support translational research that moves promising discoveries into clinical applications that will advance the prevention, diagnosis, mitigation, and/or treatment of eye injury or visual dysfunction associated with military exposure. Successful applications to the FY23 VRP TRA should establish a clear path to transforming a promising discovery into new drugs, devices, or clinical practice guidelines that are ready for definitive testing in clinical trials. For new drug or device development, the investigative team should include at least one collaborator with expertise in the regulatory approval process. For the purposes of this funding opportunity, “regulatory agency” refers to the U.S. Food and Drug Administration (FDA) or any relevant international regulatory agency unless otherwise noted. It is expected that, if applicable, an Investigational New Drug (IND)/ Investigational Device Exemption (IDE) application or international equivalent will be submitted to a regulatory agency during or by the end of the period of performance. Applicants are encouraged to leverage resources and expertise at the National Center for Advancing Translational Sciences (NCATS) to improve efficiency and accelerate the translational process. A list of NCATS programs and resources supporting preclinical innovation can be found at https://ncats.nih.gov/preclinical. The National Cancer Institute’s Translational Research Working Group (TRWG) conceptualized translational research as a set of developmental pathways leading to various clinical goals (http://clincancerres.aacrjournals.org/content/14/18/5664). Applicants may consult the TRWG pathways for guidance on the design of translational research projects. Research involving animals, human subjects, and human anatomical substances is permitted. The FY23 VRP TRA allows funding for a pilot clinical trial (PCT) component, but not a full-scale clinical trial. In contrast to full-scale clinical trials that are designed to determine safety or efficacy, the purpose of the PCT is to inform the feasibility, rationale, and design of subsequent clinical trials through limited clinical testing of a novel intervention. Applications that include a PCT component must also have non-PCT translational research component(s) (e.g., preclinical studies, non-PCT clinical studies) and will have additional submission requirements and review criteria.

## Questions people ask

### Is HT9425-23-VRP-TRA still open?

No. It closed on November 8, 2023. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DoD Vision Translational Research Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for DoD Vision Translational Research Award?

Closed November 8, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $1.6 million in total for one award.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.